Back to All News
kyron.bio today announced a €5.5M Seed Round
28/05/2025
Share
The seed funding round was led by HCVC, with the participation of Verve Ventures, Entrepreneur First, Saras Capital, and numerous reputable angel investors.
The funds will accelerate the development of kyron.bio’s proprietary glycan-engineering platform, expand the kyron.bio team and fuel preclinical studies.
Partner with Kyron Bio to make better therapies for patients.
Paris Biotech Santé - Site Cochin
27 rue du Faubourg Saint Jacques
75014 Paris, France